New diabetes clinical trial: A Trial to Assess a Co-formulation of an Insulin Analog and Pramlintide in Subjects With Type 1 Diabetes Mellitus
Published on: April 16, 2019 at 09:30PM
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: ADO09 formulation; Drug: Placebo; Drug: Symlin®; Drug: Humulin®; Drug: Humalog®
Sponsor: Adocia
Completed
http://bit.ly/2v6tVMX
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: ADO09 formulation; Drug: Placebo; Drug: Symlin®; Drug: Humulin®; Drug: Humalog®
Sponsor: Adocia
Completed
http://bit.ly/2v6tVMX
0 Comments